https://orcid.org/0000-0001-9054-5933
Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Steven L. Proctor. (2022) Rewarding recovery: the time is now for contingency management for opioid use disorder. Annals of Medicine 54:1, pages 1178-1187.
Read now
Read now
Yuri A. Maricich, Edward V. Nunes, Aimee N. C. Campbell, Jeffrey D. Botbyl & Hilary F. Luderer. (2022) Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study. Substance Abuse 43:1, pages 937-942.
Read now
Read now
Fulton F. Velez, Danmeng Huang, Lorie Mody & Daniel C. Malone. (2022) Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 599-607.
Read now
Read now
Fulton F Velez, Sam Colman, Laura Kauffman, Charles Ruetsch, Kathryn Anastassopoulos & Yuri A Maricich. (2021) Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder. ClinicoEconomics and Outcomes Research 13, pages 909-916.
Read now
Read now
Yuri A. Maricich, Robert Gerwien, Alice Kuo, Daniel C. Malone & Fulton F. Velez. (2021) Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder. Hospital Practice 49:5, pages 348-355.
Read now
Read now
Fulton F. Velez, Charles Ruetsch & Yuri Maricich. (2021) Evidence of long-term real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 519-520.
Read now
Read now
Fulton F. Velez, Hilary F. Luderer, Robert Gerwien, Benjamin Parcher, Dylan Mezzio & Daniel C. Malone. (2021) Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Postgraduate Medicine 133:4, pages 421-427.
Read now
Read now
Yuri A. Maricich, Xiaorui Xiong, Robert Gerwien, Alice Kuo, Fulton Velez, Bruce Imbert, Keely Boyer, Hilary F. Luderer, Stephen Braun & Karren Williams. (2021) Real-world evidence for a prescription digital therapeutic to treat opioid use disorder. Current Medical Research and Opinion 37:2, pages 175-183.
Read now
Read now
Articles from other publishers (23)
Jesse Dallery, Lindsey Ives & Alexandra Knerr. (2023) Toward an era of impact of digital contingency management in the treatment of substance use disorders. Preventive Medicine 176, pages 107518.
Crossref
Crossref
Sean R. Zion, Chloe J. Taub, Lauren C. Heathcote, Allison Ramiller, Stacey Tinianov, Michael McKinley, Geoff Eich, Frank J. Penedo, Patricia A. Ganz, Michael Antoni & Dianne M. Shumay. (2023) Effects of a Cognitive Behavioral Digital Therapeutic on Anxiety and Depression Symptoms in Patients With Cancer: A Randomized Controlled Trial. JCO Oncology Practice.
Crossref
Crossref
Chris Miller-Rosales, Nancy E. Morden, Mary F. Brunette, Susan H. Busch, John B. Torous & Ellen R. Meara. (2023) Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations. JAMA Network Open 6:7, pages e2323741.
Crossref
Crossref
Philana Phan, Samir Mitragotri & Zongmin Zhao. (2023) Digital therapeutics in the clinic. Bioengineering & Translational Medicine 8:4.
Crossref
Crossref
Joo Hun Yoo, Harim Jeong & Tai-Myoung Chung. (2023) Cutting-Edge Technologies for Digital Therapeutics: A Review and Architecture Proposals for Future Directions. Applied Sciences 13:12, pages 6929.
Crossref
Crossref
Noam Fast, Robin van Kessel, Keith Humphreys, Natalie Frances Ward & Andres Roman-Urrestarazu. (2023) The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review. Current Addiction Reports 10:2, pages 187-197.
Crossref
Crossref
Jin Seok Oh & Jae Ho Chung. (2023) Introduction to Digital Therapeutics. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 66:3, pages 147-155.
Crossref
Crossref
Steven L Proctor, Khary K Rigg & Allen Y Tien. (2022) Acceptability and Usability of a Reward-Based Mobile App for Opioid Treatment Settings: Mixed Methods Pilot Study. JMIR Formative Research 6:10, pages e37474.
Crossref
Crossref
Ashutosh Kumar Tripathi, Sonam Agrawal & Rajan Dev Gupta. (2021) Comparison of GIS-based AHP and fuzzy AHP methods for hospital site selection: a case study for Prayagraj City, India. GeoJournal 87:5, pages 3507-3528.
Crossref
Crossref
Fulton F. Velez, Kathryn P. Anastassopoulos, Samuel Colman, Neel Shah, Laura Kauffman, Sean M. Murphy, Charles Ruetsch & Yuri A. Maricich. (2022) Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic. Advances in Therapy 39:9, pages 4131-4145.
Crossref
Crossref
Sara N. Edmond, Danielle M. Wesolowicz, Brent A. Moore, Jennifer Ibarra, Manik Chhabra, Liana Fraenkel & William C. Becker. (2022) Opioid tapering support using a web-based app: Development and protocol for a pilot randomized controlled trial. Contemporary Clinical Trials 119, pages 106857.
Crossref
Crossref
Ki Young Huh, Jaeseong Oh, SeungHwan Lee & Kyung-Sang Yu. (2022) Clinical Evaluation of Digital Therapeutics: Present and Future. Healthcare Informatics Research 28:3, pages 188-197.
Crossref
Crossref
Tyler B Wray. (2022) Exploring Whether Addictions Counselors Recommend That Their Patients Use Websites, Smartphone Apps, or Other Digital Health Tools to Help Them in Their Recovery: Web-Based Survey. JMIR Formative Research 6:6, pages e37008.
Crossref
Crossref
Hayam Y. Giravi, Zack Biskupiak, Linda S. Tyler & Grzegorz Bulaj. (2022) Adjunct Digital Interventions Improve Opioid-Based Pain Management: Impact of Virtual Reality and Mobile Applications on Patient-Centered Pharmacy Care. Frontiers in Digital Health 4.
Crossref
Crossref
Hyo Jung Choi, Jae Yong Dong, Eun Mi Kim & Jun Ho Jang. (2022) Digital Therapeutics Reimbursement System in Germany and Its Implications. Health Insurance Review & Assessment Service Research 2:1, pages 24-35.
Crossref
Crossref
Shi Yin, Nan Zhang, Kifayat Ullah & Shuo Gao. (2022) Enhancing Digital Innovation for the Sustainable Transformation of Manufacturing Industry: A Pressure-State-Response System Framework to Perceptions of Digital Green Innovation and Its Performance for Green and Intelligent Manufacturing. Systems 10:3, pages 72.
Crossref
Crossref
Assaf Gottlieb, Christine Bakos-Block, James R. Langabeer & Tiffany Champagne-Langabeer. (2022) Sociodemographic and Clinical Characteristics Associated with Improvements in Quality of Life for Participants with Opioid Use Disorder. Healthcare 10:1, pages 167.
Crossref
Crossref
Karen Sandman & Anna Forsythe. 2022. Digital Healthcare in Germany. Digital Healthcare in Germany
97
107
.
Hannah Moshontz, Alejandra J Colmenares, Gaylen E Fronk, Sarah J Sant'Ana, Kendra Wyant, Susan E Wanta, Adam Maus, David H Gustafson Jr, Dhavan Shah & John J Curtin. (2021) Prospective Prediction of Lapses in Opioid Use Disorder: Protocol for a Personal Sensing Study. JMIR Research Protocols 10:12, pages e29563.
Crossref
Crossref
Sara J. Becker, Caitlyn A. Bowen, Ellaina N. Reed, Sharon G. Lang, Nicholas Correia, Julia Yermash, Kimberly R. Yap, Carla J. Rash & Bryan R. Garner. (2021) Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations. Drug and Alcohol Dependence Reports 1, pages 100003.
Crossref
Crossref
Ho-Jin Lee. (2021) Digital therapeutics in pain medicine. The Korean Journal of Pain 34:3, pages 247-249.
Crossref
Crossref
Jeffrey A TiceMelanie D WhittingtonJonathan D CampbellSteven D Pearson. (2021) The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder. Journal of Managed Care & Specialty Pharmacy 27:4, pages 528-532.
Crossref
Crossref
Matthew P. Normand, Jesse Dallery & Crystal M. Slanzi. (2021) Leveraging applied behavior analysis research and practice in the service of public health. Journal of Applied Behavior Analysis 54:2, pages 457-483.
Crossref
Crossref